HomeNXTG • TLV
add
Nextage Therapeutics Ltd
Previous close
ILA 58.60
Year range
ILA 6.20 - ILA 99.00
Market cap
47.50M ILS
Avg Volume
2.97K
P/E ratio
68.80
Dividend yield
-
Primary exchange
TLV
Market news
Financials
Income Statement
Revenue
Net income
| (ILS) | Dec 2024info | Y/Y change |
|---|---|---|
Revenue | 52.00K | — |
Operating expense | 829.50K | — |
Net income | -2.50M | — |
Net profit margin | -4.81K | — |
Earnings per share | — | — |
EBITDA | -807.50K | — |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (ILS) | Dec 2024info | Y/Y change |
|---|---|---|
Cash and short-term investments | 253.00K | — |
Total assets | 353.00K | — |
Total liabilities | 5.89M | — |
Total equity | -5.54M | — |
Shares outstanding | 33.70M | — |
Price to book | -3.66 | — |
Return on assets | -576.49% | — |
Return on capital | 38.21% | — |
Cash Flow
Net change in cash
| (ILS) | Dec 2024info | Y/Y change |
|---|---|---|
Net income | -2.50M | — |
Cash from operations | -133.00K | — |
Cash from investing | -94.00K | — |
Cash from financing | 168.00K | — |
Net change in cash | -29.50K | — |
Free cash flow | -491.75K | — |
About
Founded
1982
Website
Employees
31
